Vernal Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
61
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$41M
- Investors
-
6
Vernal Biosciences General Information
Description
Operator of an mRNA manufacturing company intended to provide high purity from concept to clinical trials, on a transactional basis. The company focuses on mRNA and LNP-mRNA manufacturing for use in cells, animals, and humans to address all mRNA-based life science needs, enabling research professionals with on-demand, high-purity mRNA for all of their R&D needs.
Contact Information
Website
www.vernal.bioCorporate Office
- 261 Mountain View Drive
- Colchester, VT 05446
- United States
Corporate Office
- 261 Mountain View Drive
- Colchester, VT 05446
- United States
Vernal Biosciences Timeline
Vernal Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 14-Jun-2023 | $41M | Completed | Generating Revenue | ||
| 1. Seed Round | 24-May-2021 | Completed | Generating Revenue |
Vernal Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
Vernal Biosciences Comparisons
Industry
Financing
Details
Vernal Biosciences Competitors (68)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verge Genomics | Venture Capital-Backed | South San Francisco, CA | ||||
| Cerecin | Venture Capital-Backed | Singapore, Singapore | ||||
| Vividion Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| AUM Biosciences | Venture Capital-Backed | Singapore, Singapore | ||||
| CytImmune Sciences | Private Equity-Backed | Rockville, MD |
Vernal Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vernal Biosciences Executive Team (3)
| Name | Title | Board Seat |
|---|---|---|
| Christian Cobaugh Ph.D | Founder, Chief Executive Officer, President & Board Member | |
| Richard Hamel | Chief Financial Officer | |
| Sven Lee | Chief Commercial Officer |
Vernal Biosciences Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christian Cobaugh Ph.D | Vernal Biosciences | Founder, Chief Executive Officer, President & Board Member | |
| Daniella Kranjac | Dynamk Capital | Board Member | |
| David Anderson Ph.D | Ampersand Capital Partners | Board Member | |
| Errik Anderson | Alloy Therapeutics | Board Member | |
| Gustavo Mahler Ph.D | Dynamk Capital | Board Member |
Vernal Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vernal Biosciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ampersand Capital Partners | Growth/Expansion | Minority | ||
| Charles River Laboratories International | Corporation | Minority | ||
| Dynamk Capital | Venture Capital | Minority | ||
| Echo Investment Capital | Corporate Venture Capital | Minority | ||
| Alloy Therapeutics | VC-Backed Company | Minority |
Vernal Biosciences FAQs
-
When was Vernal Biosciences founded?
Vernal Biosciences was founded in 2020.
-
Who is the founder of Vernal Biosciences?
Christian Cobaugh Ph.D is the founder of Vernal Biosciences.
-
Who is the CEO of Vernal Biosciences?
Christian Cobaugh Ph.D is the CEO of Vernal Biosciences.
-
Where is Vernal Biosciences headquartered?
Vernal Biosciences is headquartered in Colchester, VT.
-
What is the size of Vernal Biosciences?
Vernal Biosciences has 61 total employees.
-
What industry is Vernal Biosciences in?
Vernal Biosciences’s primary industry is Drug Discovery.
-
Is Vernal Biosciences a private or public company?
Vernal Biosciences is a Private company.
-
What is the current valuation of Vernal Biosciences?
The current valuation of Vernal Biosciences is .
-
What is Vernal Biosciences’s current revenue?
The current revenue for Vernal Biosciences is .
-
How much funding has Vernal Biosciences raised over time?
Vernal Biosciences has raised $42.5M.
-
Who are Vernal Biosciences’s investors?
Ampersand Capital Partners, Charles River Laboratories International, Dynamk Capital, Echo Investment Capital, and Alloy Therapeutics are 5 of 6 investors who have invested in Vernal Biosciences.
-
Who are Vernal Biosciences’s competitors?
Verge Genomics, Cerecin, Vividion Therapeutics, AUM Biosciences, and CytImmune Sciences are some of the 68 competitors of Vernal Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
